Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
出版年份 2016 全文链接
标题
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 23, Issue 4, Pages R185-R205
出版商
Bioscientifica
发表日期
2016-05-24
DOI
10.1530/erc-15-0555
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.
- (2017) Marcia S. Brose et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
- (2015) Maria E. Cabanillas et al. CANCER
- Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
- (2015) Y. Koguchi et al. CANCER RESEARCH
- A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
- (2015) M. Schlumberger et al. CLINICAL CANCER RESEARCH
- Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
- (2015) Francis Worden et al. ENDOCRINE-RELATED CANCER
- Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group
- (2015) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E-Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience
- (2015) Ramona Dadu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
- (2015) Elizabeth G. Grubbs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
- (2015) Mingzhao Xing et al. JOURNAL OF CLINICAL ONCOLOGY
- Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma
- (2015) Yann Godbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer
- (2015) Jun Ho Ji et al. PLoS Genetics
- Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome
- (2015) Fabián Pitoia et al. Archives of Endocrinology Metabolism
- Upregulation of HGF and c-MET is Associated with Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
- (2014) Bon Seok Koo et al. ANNALS OF SURGICAL ONCOLOGY
- Response to sorafenib treatment in advanced metastatic thyroid cancer
- (2014) Fabian Pitoia Arquivos Brasileiros de Endocrinologia e Metabologia
- Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments
- (2014) Laura D. Locati et al. CANCER
- Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
- (2014) T. Nakaoku et al. CLINICAL CANCER RESEARCH
- Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens
- (2014) Thomas J. Giordano et al. HUMAN PATHOLOGY
- Development and Characterization of a Differentiated Thyroid Cancer Cell Line Resistant to VEGFR-Targeted Kinase Inhibitors
- (2014) Crescent R. Isham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H
- (2014) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
- (2014) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Complete Resolution of Hypercortisolism with Sorafenib in a Patient with Advanced Medullary Thyroid Carcinoma and Ectopic ACTH (Adrenocorticotropic Hormone) Syndrome
- (2014) Romualdo Barroso-Sousa et al. THYROID
- Definition and management of radioactive iodine-refractory differentiated thyroid cancer
- (2014) Martin Schlumberger et al. Lancet Diabetes & Endocrinology
- Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
- (2013) E. Fox et al. CLINICAL CANCER RESEARCH
- Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy
- (2013) Devron R. Shah et al. DRUG SAFETY
- Radioactive iodine in the treatment of medullary thyroid carcinoma: a controlled multicenter study
- (2013) J A A Meijer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- (2013) Mingzhao Xing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
- (2013) R. C. Smallridge et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversal of Cushing's Syndrome by Vandetanib in Medullary Thyroid Carcinoma
- (2013) Camille Baudry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer
- (2013) C. R. Isham et al. Science Translational Medicine
- Thyroid Cancer Incidence Patterns in Sao Paulo, Brazil, and the U.S. SEER Program, 1997–2008
- (2013) Lene H.S. Veiga et al. THYROID
- Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma
- (2013) Julie A. Sosa et al. THYROID
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2012) Bassam Estfan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A Missing Link in Genotype-Directed Cancer Therapy
- (2012) René Bernards CELL
- Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
- (2012) Vincenzo Marotta et al. CLINICAL ENDOCRINOLOGY
- Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma
- (2012) Maria E Cabanillas et al. ENDOCRINE-RELATED CANCER
- Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
- (2012) Cristina Romei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer
- (2012) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
- (2012) Sophie Leboulleux et al. LANCET ONCOLOGY
- RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation
- (2012) P Ballerini et al. LEUKEMIA
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- Advances in the follow-up of differentiated or medullary thyroid cancer
- (2012) Rossella Elisei et al. Nature Reviews Endocrinology
- Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
- (2012) Shu-Fu Lin et al. PLoS One
- Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
- (2012) K. Ohashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imatinib Enhances Docetaxel-Induced Apoptosis Through Inhibition of Nuclear Factor-κB Activation in Anaplastic Thyroid Carcinoma Cells
- (2012) EunSook Kim et al. THYROID
- Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
- (2012) Raffaele Ciampi et al. THYROID
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
- (2012) Panayiotis Savvides et al. THYROID
- Higher rate of BRAF mutation in papillary thyroid cancer over time
- (2011) Aarti Mathur et al. CANCER
- Cancer cells harboring MET gene amplification activate alternative signaling pathways to escape MET inhibition but remain sensitive to Hsp90 inhibitors
- (2011) Suiquan Wang et al. CELL CYCLE
- Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer
- (2011) N. Jin et al. CLINICAL CANCER RESEARCH
- Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
- (2011) Paula Soares et al. CURRENT GENOMICS
- Molecular Analysis of Thyroid Tumors
- (2011) Feriyl Bhaijee et al. ENDOCRINE PATHOLOGY
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
- (2011) Debyani Chakravarty et al. JOURNAL OF CLINICAL INVESTIGATION
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Multikinase inhibitors: a new option for the treatment of thyroid cancer
- (2011) Matti L. Gild et al. Nature Reviews Endocrinology
- Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
- (2011) Akira Miyauchi et al. THYROID
- THE EFFECT OF RADIOACTIVE IODINE TREATMENT ON THYROID C CELLS
- (2010) MIYASE BAYRAKTAR et al. CLINICAL ENDOCRINOLOGY
- Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib
- (2010) Brady Stein et al. CLINICAL THERAPEUTICS
- Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
- (2010) D. Deandreis et al. ENDOCRINE-RELATED CANCER
- VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma
- (2010) Z Karaca et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus
- (2010) Dingxie Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- BRAF V600E mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer
- (2010) Monica Zerilli et al. MODERN PATHOLOGY
- Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer
- (2010) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Increased Expression of Vascular Endothelial Growth Factor and Its Receptors, VEGFR-1 and VEGFR-2, in Medullary Thyroid Carcinoma
- (2010) Clarissa Capp et al. THYROID
- Expression of hypoxia-inducible factor 1α in thyroid carcinomas
- (2009) N Burrows et al. ENDOCRINE-RELATED CANCER
- Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
- (2009) Ning Jin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
- (2008) Robert C Smallridge et al. ENDOCRINE-RELATED CANCER
- Intragenic Mutations in Thyroid Cancer
- (2008) Manuel Sobrinho-Simões et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
- (2008) Anne Laure Giraudet et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
- (2008) Zhi Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer
- (2007) Libero Santarpia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinicopathological Analysis of Papillary Thyroid Cancer withPIK3CAAlterations in a Middle Eastern Population
- (2007) Jehad Abubaker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started